Research progress of primary prevention for stroke: reports from China

Abstract

Chinese researchers have published some studies in English journals in the past 2 years. These studies focused on status and costs of primary prevention for stroke, warfarin for atrial fibrillation (AF), angiotensin converting enzyme inhibitor (ACEI) and angiotensin Ⅱ receptor blocker (ARB) for diabetes mellitus, vitamin B supplementation for reducing plasm homocysteine level and the risk of cerebrovascular disease, non-high-density lipoprotein cholesterol (non-HDL-C) levels and asymptomatic intracranial arterial stenosis, and Qigong exercises for the prevention of stroke. In this review, we outline the data on primary prevention for stroke and review the risk factors and their management.

DOI: 10.3969/j.issn.1672-6731.2015.01.004